The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tremelimumab in combination with durvalumab in first or second-line mesothelioma patients: Safety analysis from the phase II NIBIT-MESO-1 study.
 
Luana Calabro
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Aldo Morra
No Relationships to Disclose
 
Diana Giannarelli
No Relationships to Disclose
 
Giovanni Amato
No Relationships to Disclose
 
Erica Bertocci
No Relationships to Disclose
 
Armida D'Incecco
No Relationships to Disclose
 
Riccardo Danielli
No Relationships to Disclose
 
Lucia Brilli
No Relationships to Disclose
 
Fabio Giannini
No Relationships to Disclose
 
Maresa Altomonte
No Relationships to Disclose
 
Anna Maria Di Giacomo
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michele Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Incyte
Research Funding - AstraZeneca; Bristol-Myers Squibb